News

Standalone & Consolidated Financial Results, Form A, Auditors Report for March 31, 2016

May 5, 2016 9:56 am Published by

Span Diagnostics Ltd has informed BSE about :

  1. Standalone Financial Results for the period ended March 31, 2016
  2. Consolidated Financial Results for the period ended March 31, 2016
  3. Standalone Form A for the period ended March 31, 2016
  4. Consolidated Form A for the period ended March 31, 2016
  5. Standalone Auditors Report for the period ended March 31, 2016
  6. Consolidated Auditors Report for the period ended March 31, 2016

Outcome of Board Meeting

May 4, 2016 9:51 am Published by

Span Diagnostics Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 05, 2016, inter alia, has transacted the following:

  1. In view of operating loss during the year and considering future plans of the Company, directors do not recommend dividend for the year ended on March 31, 2016.
  2. Board approved appointment of Mr. Viral P. Desai as Managing Director of the Company with effect from July 01, 2016 for a period of three years.

Disinvestment of stake held in Joint Venture Company

November 20, 2015 9:58 am Published by

With reference to the earlier letter dated March 24, 2015, Span Diagnostics Ltd has now informed BSE that the Company has disinvested its entire 45% stake held in Joint Venture Company namely Span Nihon Kohden Diagnostics Private Limited to Nihon Khoden Corporation, Japan on November 19, 2015 for consideration of Rs.8,02,00,000/- (Rupees Eight Crore Two Lacs Only).

Updates on Post Delisting Offer

November 18, 2015 9:58 am Published by

Span Diagnostics Ltd has submitted to BSE a Copy of Completion of extinguishment/ destruction of a total of 18,14,253 Equity Shares of Span Divergent Limited (“Target Companyā€¯) formerly known as Span Diagnostics Limited. (“Buyback Offer”).

Post Buy back Offer

October 23, 2015 10:00 am Published by

Arihant Capital Markets Ltd (“Manager to the Buy back Offer”) has submitted to BSE a Coy of Post Buy back Public Announcement (“PA”) to the Equity Shareholders/ beneficial owners of the Equity Shares of Span Diagnostics Ltd (“Target Company”) in pursuant to Regulation 19(7) of the Securities and Exchange Board of India (Buy-back of Securities ) Regulations, 1998, as amended, (“SEBI Buyback Regulations”).